RESULTS OF THE TREATMENT OF SYSTEMIC MYCOSES.
D000196:Actinomycosis; D000666:Amphotericin B; D035843:Biomedical Research; D001759:Blastomycosis; D002177:Candidiasis; D003047:Coccidioidomycosis; D003453:Cryptococcosis; D003523:Cycloserine; D004917:Erythromycin; D006660:Histoplasmosis; D006801:Humans; D009181:Mycoses; D009617:Nocardia Infections; D010406:Penicillins; D010600:Pharmacology; D013174:Sporotrichosis; D013266:Stilbamidines; D013416:Sulfamerazine; D013752:Tetracycline
D010406:Penicillins; D013266:Stilbamidines; C100274:hydroxystilbamidine; D004917:Erythromycin; D000666:Amphotericin B; D003523:Cycloserine; D013752:Tetracycline; D013416:Sulfamerazine
ACTINOMYCOSIS; AMPHOTERICIN B; BLASTOMYCOSIS; CLINICAL RESEARCH; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CYCLOSERINE; ERYTHROMYCIN; HISTOPLASMOSIS; HYDROXYSTILBAMIDINE; MONILIASIS; NOCARDIA INFECTIONS; PENICILLIN; PHARMACOLOGY; SPOROTRICHOSIS; STILBAMIDINES; SULFAMERAZINE; TETRACYCLINE